These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Improvement of idiopathic pyoderma gangrenosum during treatment with anti-tumor necrosis factor alfa monoclonal antibody. Dini V; Romanelli M; Bertone M; Talarico S; Bombardieri S; Barachini P Int J Low Extrem Wounds; 2007 Jun; 6(2):108-13. PubMed ID: 17558009 [TBL] [Abstract][Full Text] [Related]
11. Implications of a local overproduction of tumor necrosis factor-α in complex regional pain syndrome. Walker S; Drummond PD Pain Med; 2011 Dec; 12(12):1784-807. PubMed ID: 22082181 [TBL] [Abstract][Full Text] [Related]
12. Targeting tumor necrosis factor-alpha in the therapy of psoriasis. Gisondi P; Gubinelli E; Cocuroccia B; Girolomoni G Curr Drug Targets Inflamm Allergy; 2004 Jun; 3(2):175-83. PubMed ID: 15180471 [TBL] [Abstract][Full Text] [Related]
13. Sarcoidosis, role of tumor necrosis factor inhibitors and other biologic agents, past, present, and future concepts. Sweiss NJ; Curran J; Baughman RP Clin Dermatol; 2007; 25(3):341-6. PubMed ID: 17560312 [TBL] [Abstract][Full Text] [Related]
14. Cytokine targeting in psoriasis and psoriatic arthritis: beyond TNFalpha. MclInnes IB Ernst Schering Res Found Workshop; 2006; (56):29-44. PubMed ID: 16329645 [TBL] [Abstract][Full Text] [Related]
15. Mechanisms for modulating TNF alpha in immune and inflammatory disease. Baugh JA; Bucala R Curr Opin Drug Discov Devel; 2001 Sep; 4(5):635-50. PubMed ID: 12825458 [TBL] [Abstract][Full Text] [Related]
16. From Bedside to Bench: the Role of Anti-Tumor Necrosis Factor Agents in the Management of Immune-Mediated Inflammatory Diseases. Haraoui B; Russell AS; Keystone EC J Rheumatol Suppl; 2010 May; 85():1. PubMed ID: 20436160 [No Abstract] [Full Text] [Related]
17. Tumour necrosis factor-alpha as a new therapeutic target for rheumatoid arthritis: an update. Giasuddin AS; Hoque ME; Ahmed ZU Bangladesh Med Res Counc Bull; 2005 Dec; 31(3):88-94. PubMed ID: 17549869 [TBL] [Abstract][Full Text] [Related]
18. The role of TNFalpha in ulcerative colitis. Sands BE; Kaplan GG J Clin Pharmacol; 2007 Aug; 47(8):930-41. PubMed ID: 17567930 [TBL] [Abstract][Full Text] [Related]
19. Potential target of infliximab in autoimmune and inflammatory diseases. Atzeni F; Doria A; Carrabba M; Turiel M; Sarzi-Puttini P Autoimmun Rev; 2007 Sep; 6(8):529-36. PubMed ID: 17854744 [TBL] [Abstract][Full Text] [Related]
20. Optimizing use of tumor necrosis factor inhibitors in the management of immune-mediated inflammatory diseases. Bressler B; Haraoui B; Keystone E; Sette A J Rheumatol Suppl; 2010 May; 85():40-52. PubMed ID: 20436164 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]